Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dumbani, M."'
Publikováno v:
International Journal of Nanomedicine, Vol Volume 14, Pp 7861-7878 (2019)
Tony Bewersdorff,1 Alexandra Gruber,2 Murat Eravci,1 Malti Dumbani,1 Daniel Klinger,2 Andrea Haase1 1German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany; 2Freie Universität Berlin, Institute
Externí odkaz:
https://doaj.org/article/c159323ffa504e39b90787a122145186
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kobelt, D., Dahlmann, M., Dumbani, M., Güllü, N., Kortüm, B., Vílchez, M.E.A., Stein, U., Walther, W.
Metastasis represents the most lethal attribute of cancer and critically limits successful therapies in many tumor entities. The clinical need is defined by the fact that all cancer patients, who have or who will develop distant metastasis, will expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::4a3c106f75a04394639ed11683992115
http://edoc.mdc-berlin.de/19033/1/19033oa.pdf
http://edoc.mdc-berlin.de/19033/1/19033oa.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Adhikary PP; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Idowu T; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Tan Z; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Hoang C; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Shanta S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Dumbani M; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany., Mappalakayil L; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Awasthi B; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Bermudez M; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.; Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany., Weiner J; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany., Beule D; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany., Wolber G; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany., Page BDG; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. brent.page@ubc.ca., Hedtrich S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. sarah.hedtrich@bih-charite.de.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany. sarah.hedtrich@bih-charite.de.; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. sarah.hedtrich@bih-charite.de.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany. sarah.hedtrich@bih-charite.de.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Dec; Vol. 16 (12), pp. 3247-3250.
Autor:
Kobelt D; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Dahlmann M; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Dumbani M; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Güllü N; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Kortüm B; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Vílchez MEA; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Stein U; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Walther W; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jun 03; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 03.